Completed Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions. NCT07428941 Conditions Actinic Keratoses, Bacterial Infections, Bacterial Infections and Mycoses, +40 more Locations AI Labs Group S.L. — Bilbao, Basque Country, Spain View Trial Details
Completed Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) NCT03885089 Conditions Arthritis, Arthritis, Psoriatic, Bone Diseases, +14 more Locations Pfizer Local Country Office — Tokyo, Japan View Trial Details
Completed Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP NCT05215561 Conditions Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more Locations Novartis Investigative Site — Nagoya, Aichi-ken, Japan Novartis Investigative Site — Fukuoka, Japan Novartis Investigative Site — Kitakyushu, Fukuoka, Japan Novartis Investigative Site — Obihiro, Hokkaido, Japan View all 21 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Anakinra for Inflammatory Pustular Skin Diseases NCT01794117 Conditions Acrodermatitis Continua of Hallopeau, Palmoplantar Pustulosis, Psoriasis, +6 more Locations National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States View Trial Details
Completed An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis NCT02343744 Conditions Psoriasis, Pustular Psoriasis, Skin Diseases, +2 more Locations Asahikawa, Japan Fukuoka, Japan Gifu, Japan Izumo, Japan View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
